OpGen, Inc.
OTC: OPGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Christian-Laurent Benoit Bonte
- Employees
- 85
- Headquarters
- Rockville, United States
- IPO year
- 2015
- Market cap
- $242.7M
- Website
- https://www.opgen.com
Loading OPGN…
Loading profile data…Frequently asked questions about OPGN
What does OpGen, Inc. (OPGN) do?
OpGen, Inc. is a precision medicine company dedicated to developing and commercializing advanced molecular microbiology solutions for both U.S. and international markets. Its comprehensive product suite includes the Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test designed to pinpoint various bacterial nucleic acids and genetic markers...
Where does OPGN trade?
OpGen, Inc. (OPGN) trades on the Other OTC.
What sector is OPGN in?
OpGen, Inc. (OPGN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of OpGen, Inc.?
Christian-Laurent Benoit Bonte is the chief executive officer of OpGen, Inc. (OPGN).
Where is OpGen, Inc. headquartered?
OpGen, Inc. is headquartered in United States.
Does OPGN pay a dividend?
OpGen, Inc. (OPGN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did OPGN go public?
OpGen, Inc. (OPGN) completed its initial public offering in 2015.